PERSPECTA

News from every angle

← Back to headlines

Johnson & Johnson Focuses on Cancer and Neuroscience as Top Dividend Stock

Johnson & Johnson (JNJ) is highlighted as a top dividend aristocrat stock, with its strategic focus on cancer and neuroscience driving its investment appeal.

1 Jul, 19:54 — 1 Jul, 19:54
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual42d ago

Johnson & Johnson (JNJ): Focused on Cancer and Neuroscience as a Top Dividend Aristocrat Stock to Buy

Read full article →

Related Stories

Workday Shares Surge on Silver Lake Takeover Report

12m ago

OpenAI Sees Second Executive Departure This Week with Denise Dresser

58m ago

Eagle Point Credit Company Declares Multiple Dividends and Reports Q2 Earnings

1h ago

Large Explosion Reported at Ammunition Factory Near Rome

1h ago